In an abdominal aortic constriction model of heart failure, the CGRP analog attenuated cardiac hypertrophy and apoptosis, demonstrating a beneficial effect of chronic CGRP treatment in heart failure over several weeks (Aubdool et al., 2017). Here, CALCA is linked to cardiac hypertrophy.